Loading...
Morgan Stanley
MS-PE•NYSE
Financial ServicesFinancial - Capital Markets
$25.48
$0.01(0.04%)
Morgan Stanley (MS-PE) Financial Performance & Statements
Review Morgan Stanley’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
14.71%
↑ 14.71%
Operating Income Growth
25.44%
↑ 25.44%
Net Income Growth
47.35%
↑ 47.35%
Operating Cash Flow Growth
104.06%
↑ 104.06%
Operating Margin
17.73%
↑ 17.73%
Gross Margin
56.30%
↑ 56.30%
Net Profit Margin
13.52%
↑ 13.52%
ROE
14.01%
↑ 14.01%
ROIC
3.94%
↑ 3.94%
Morgan Stanley (MS-PE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Morgan Stanley stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $16.11B | $13.19B | $14.94B | $15.14B |
| Cost of Revenue | $0.00 | $7.92B | $0.00 | $0.00 |
| Gross Profit | $16.11B | $5.27B | $0.00 | $0.00 |
| Gross Profit Ratio | $1.00 | $0.40 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.89B | $6.96B | $7.92B | $7.99B |
| Operating Expenses | $7.89B | $224.00M | $7.92B | $7.99B |
| Total Costs & Expenses | $7.89B | $8.14B | $7.92B | $7.99B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$3.52B | $1.27B | $1.27B | $975.00M |
| EBITDA | -$5.16B | $5.05B | $5.03B | $5.35B |
| EBITDA Ratio | -$0.32 | $0.38 | $0.34 | $0.35 |
| Operating Income | $8.21B | $5.49B | $7.02B | $7.15B |
| Operating Income Ratio | $0.51 | $0.42 | $0.47 | $0.47 |
| Other Income/Expenses (Net) | -$3.31B | -$1.27B | -$1.27B | -$975.00M |
| Income Before Tax | $4.91B | $4.22B | $4.07B | $4.39B |
| Income Before Tax Ratio | $0.30 | $0.32 | $0.27 | $0.29 |
| Income Tax Expense | $1.18B | $995.00M | $957.00M | $933.00M |
| Net Income | $3.71B | $3.19B | $3.08B | $3.41B |
| Net Income Ratio | $0.23 | $0.24 | $0.21 | $0.23 |
| EPS | $2.13 | $1.91 | $1.85 | $2.04 |
| Diluted EPS | $2.22 | $1.88 | $1.82 | $2.02 |
| Weighted Avg Shares Outstanding | $1.58B | $1.59B | $1.59B | $1.60B |
| Weighted Avg Shares Outstanding (Diluted) | $1.61B | $1.61B | $1.61B | $1.62B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan